CN101313984A - Medicament for treating appendicitis - Google Patents
Medicament for treating appendicitis Download PDFInfo
- Publication number
- CN101313984A CN101313984A CNA2008101406962A CN200810140696A CN101313984A CN 101313984 A CN101313984 A CN 101313984A CN A2008101406962 A CNA2008101406962 A CN A2008101406962A CN 200810140696 A CN200810140696 A CN 200810140696A CN 101313984 A CN101313984 A CN 101313984A
- Authority
- CN
- China
- Prior art keywords
- medicine
- portions
- appendicitis
- people
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to a clinic therapeutic medicine. The raw materials by weight portion of the medicine for treating appendicitis are: 300 to 360 portions of garlic, 20 to 40 portions of pearl powder, 10 to 20 portions of rhubarb, 15 to 30 portions of aucklandia root, 20 to 40 portions of homalomena rhizoma, 10 to 20 portions of fruit of sweet orange and 5 to 10 portions of croton. The medicine is used for treating acute appendicitis and chronic appendicitis; people only need to apply the medicine on an appendix mcburney point when the medicine is used, and the normal life is not affected; the pain begins to be eased after application of the medicine for 30 to 90 minutes, and the illness state is basically controlled within 3 to 5 hours; and the effective rate is 99 percent (except suppuration, perforation and necrosis). The reactions after application of the medicine are as follows: after application of the medicine for 30 to 90 minutes, the local skin has burning heat sensation and is slightly painful; inflammation can be generated on the skin of one part of people, and dispersive bubbles can be generated on a small number of people; and the inflammation and the dispersive bubbles disappear after 3 to 6 days without any sore left.
Description
Technical field
The invention belongs to the clinical treatment medicine, relate generally to the typhlitic medicine of a kind of treatment, be used for acute and chronic appendicitis is carried out the medicine application treatment.
Background technology
Vermiform appendix is the cradle of human body ying-qi as the vitals of human body, seeks to be congenital just healthy energy.The vermiform appendix function normally then makes the human body resistance against diseases increase, and Henan medical and health newspaper report: the surgeon of Duke Univ USA's medical college and immunologist deliver research report and say: the real effect of vermiform appendix is to be intestines manufacturing and protection bacteria beneficial.As if the report of delivering on Britain's " theoretical biology magazine " website is said: the effect of vermiform appendix is relevant with a large amount of antibacterials in the digestion, antibacterial is also more than the human cell in the normal human, wherein great majority are probioticss, can promote digesting and assimilating of food.On theory of Chinese medical science, interior through cloud: " healthy energy internal memory, heresy can not be done, positive QI-insufficiency, pathogen must be invaded ", must cause inflammation to take place, cause heating, pain, the typhlitic cause of disease then is to cause the generation of inflammation because of being gathered in vermiform appendix in damp and hot.
Summary of the invention
The objective of the invention is to propose the typhlitic medicine of a kind of treatment, be used to stick the affected part appendicitis is played therapeutical effect.
The raw material of medicine of the present invention and weight proportion (part):
Bulbus Allii 300-360 Margarita powder 20-40 Radix Et Rhizoma Rhei 10-20 Radix Aucklandiae 15-30 QIANNIANXIU 20-40 amasss real 10-20 Fructus Crotonis 5-10
During the present invention forms:
Bulbus Allii, nature and flavor: Xin Wen, gas is smelly, effect: go into the gastrointestinal warp, energy removing mass, cold expelling;
Margarita powder, nature and flavor: sweet light halogen is cold, effect: heat clearing away, granulation promoting, detoxifcation;
Long-pending real, nature and flavor: bitterness, return stomach, large intestine channel, effect: the clear turbid retardance of large intestine expectorant;
The Radix Aucklandiae, nature and flavor: little hardship, effect: circulation of qi promoting, pain relieving in the accent, the benefaction QI stagnation of the large intestine, it is painful to control damp and hot abdomen;
Fructus Crotonis, nature and flavor: the property suffering is puckery, effect: drastic purgation is cold long-pending, the detumescent of relieving oedema or abdominal distension through diuresis or purgation, logical intestinal moistens just intestinal lavage stomach, removing mass heat;
Radix Et Rhizoma Rhei, nature and flavor: bitter cold, return taste, large intestine, effect: heat and toxic materials clearing away, bowel relieving is stagnant, and pathopyretic ulcer is stronger with Radix Et Rhizoma Rhei catharsis power, desires the person of capturing and should use and give birth to, and processed with wine rushes down greatly a little less than the power, invigorates blood circulation that it is better to act on, and also should be used for blood stasis;
Bulbus Fritillariae davidii, nature and flavor: bitter cold, return lung meridian, effect: reduce phlegm, the heat clearing away eliminating stagnation is controlled sore and toxic, and cough-relieving is relievingd asthma;
QIANNIANXIU, nature and flavor: halogen, return large intestine channel, little poison is arranged, effect: can lead to large intestine, small intestinal, removing mass is poly-.
In preparation material medicine of the present invention, Bulbus Allii is a principal agent, because of the greatly basic medicine of consumption, and function: detumescence heat clearing away.Margarita powder is a ministerial drug, has heat clearing and damp drying, a function of eliminating the phlegm.Long-pending is adjuvant drug in fact, has ability unobstructed, relaxing the bowels with lubricant drugs.Radix Et Rhizoma Rhei is the history medicine, has the function of capturing, clearing up intestinal.Fructus Crotonis is the history medicine, have relieve oedema or abdominal distension through diuresis or purgation, function that removing mass heating power is fast.The Radix Aucklandiae is an accessory drugs, has qi and blood circulation promotion, the function that relieves the pain.Bulbus Fritillariae davidii is an accessory drugs, has lung moistening, penetration is strong, promotes the absorption of skin to medicine.QIANNIANXIU is an accessory drugs, has the effect of relieving constipation antiinflammatory.
The above-mentioned raw materials medicine is processed into powdery, and Bulbus Allii is made pasty state, again raw material powder is evenly admixed Bulbus Allii paste, promptly obtains ointment of the present invention.Ointment is spread out on the absorbent cotton gauze and stick on the vermiform appendix Maxwell fixing getting final product, and the time is according to age, build, and the absorption speed of medicine is decided, and is no more than 10 hours at most.
After ointment of the present invention is affixed on the vermiform appendix mcBurney point, by the contact skin pore to drug absorption, infiltration, thereby reach the effect of anti-inflammatory analgetic.
Medicine of the present invention is used for acute and chronic typhlitic treatment, external application is affixed on the vermiform appendix Maxwell and gets final product during use, does not influence orthobiosis, and 30-90 minute pain begins to alleviate behind the subsides medicine, 3-5 hour basic controlling state of an illness, effective percentage 99% (except that suppuration, perforation, necrosis).Reaction after the medicine medication of the present invention: 30-90 minute local skin has burning sensation, hypodynia after pasting medicine, and redness can appear in some application on human skin, and a few peoples have and are dispersed in blister, disappears substantially after 3-6 days, do not stay any skin ulcer to hinder.
The specific embodiment
Provide the embodiment of the invention:
Embodiment 1
Its material medicine and proportioning:
Bulbus Allii 360g, Margarita powder 40g, long-pending real 20g, Radix Et Rhizoma Rhei 20g (processed with wine), Fructus Crotonis 10g, Radix Aucklandiae 20g, Bulbus Fritillariae davidii 30g, the QIANNIANXIU 40g of frying.
Embodiment 2
Its material medicine and proportioning:
Bulbus Allii 300g, Margarita powder 20g, long-pending real 15g, Radix Et Rhizoma Rhei 18g (processed with wine), Fructus Crotonis 5g, Radix Aucklandiae 15g, Bulbus Fritillariae davidii 20g, the QIANNIANXIU 30g of frying.
Embodiment 3
Its material medicine and proportioning:
Bulbus Allii 350g, Margarita powder 15g, long-pending real 10g, Radix Et Rhizoma Rhei 15g (processed with wine), Fructus Crotonis 5g, Radix Aucklandiae 15g, Bulbus Fritillariae davidii 15g, the QIANNIANXIU 20g of frying.
Claims (2)
1, the typhlitic medicine of a kind of treatment, it is characterized in that: the raw material of medicine of the present invention and weight proportion (part) are: Bulbus Allii 300-360 Margarita powder 20-40 Radix Et Rhizoma Rhei 10-20 Radix Aucklandiae 15-30 QIANNIANXIU 20-40 amasss real 10-20 Fructus Crotonis 5-10.
2, a kind of method for preparing treatment appendicitis medicine is characterized in that: Bulbus Allii is made pasty state, other crude drug is processed into powdery, again raw material powder is evenly admixed Bulbus Allii paste, promptly obtain ointment; Ointment is spread out on the absorbent cotton gauze and stick on the vermiform appendix Maxwell fixing getting final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101406962A CN101313984A (en) | 2008-07-18 | 2008-07-18 | Medicament for treating appendicitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101406962A CN101313984A (en) | 2008-07-18 | 2008-07-18 | Medicament for treating appendicitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101313984A true CN101313984A (en) | 2008-12-03 |
Family
ID=40105228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101406962A Pending CN101313984A (en) | 2008-07-18 | 2008-07-18 | Medicament for treating appendicitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101313984A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614419A (en) * | 2012-04-09 | 2012-08-01 | 蒋金洲 | Chinese medicinal pills for treating acute and chronic appendicitis |
-
2008
- 2008-07-18 CN CNA2008101406962A patent/CN101313984A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614419A (en) * | 2012-04-09 | 2012-08-01 | 蒋金洲 | Chinese medicinal pills for treating acute and chronic appendicitis |
| CN102614419B (en) * | 2012-04-09 | 2013-11-06 | 蒋金洲 | Chinese medicinal pills for treating acute and chronic appendicitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102293860B (en) | Traditional Chinese medicine for treating diarrhea | |
| CN103550298B (en) | Traditional Chinese medicine externally-used patch for treating allergic rhinitis and preparation method thereof | |
| CN102218086A (en) | Traditional Chinese medicine ointment for treating hemorrhoids | |
| CN104784245A (en) | Medicine for treating cervical cancer | |
| CN104189725A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN104189268B (en) | A kind of Chinese materia medica preparation for treating postpartum irregular menstruation | |
| CN101313984A (en) | Medicament for treating appendicitis | |
| CN103263586B (en) | Traditional Chinese medicinal composition for treating mycotic enteritis | |
| CN103610916B (en) | Traditional Chinese medicine preparation for treating arteriosclerosis | |
| CN103169853B (en) | Traditional Chinese medicine composition for treating kidney yin deficiency type aplastic anemia | |
| CN103394009B (en) | Traditional Chinese medicine for treating trauma and diabetes foot ulcer and preparation method | |
| CN106668552A (en) | Medicine bag for treating deficiency of kidney | |
| CN104825939A (en) | Traditional Chinese medicine preparation for treating lumbar muscle strain | |
| CN104666922A (en) | Chinese medicinal composition for treating irregular menstruation due to deficiency of qi in spleen and kidney | |
| CN104815305A (en) | Traditional Chinese medicine for treating infantile diarrhea | |
| CN104225009A (en) | Traditional Chinese medicine composition for treating diarrhea | |
| CN103623377B (en) | A kind of medicine for the treatment of arthromyodynia and preparation method thereof | |
| CN109771591A (en) | A kind of clearing damp is by numbness wine and preparation method thereof | |
| CN109865062A (en) | A kind of Chinese medicine composition for treating vertigo | |
| CN107184898A (en) | A kind of oral traditional Chinese medicine composition for treating diarrhoea | |
| CN106334141A (en) | Traditional Chinese medicine for removing acne and eliminating sores | |
| CN107441334A (en) | A kind of Chinese medicine composition for treating deficiency of both qi and yin with blood stasis type type II diabetes | |
| CN106822760A (en) | A kind of decoction medicine for treating damp-heat accumulation type fatty liver and preparation method thereof | |
| CN106377689A (en) | Traditional Chinese medicine preparation capable of treating acute cholecystitis | |
| CN106310091A (en) | Traditional Chinese medicine for treating tachycardia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20081203 |